Florida Company Recalls X10 Natural Enhancement Supplement Nationwide After FDA Finds Hidden Prescription Drug Ingredients

Clermont, Fla. — A Florida-based company is recalling a natural male enhancement supplement distributed nationwide after federal laboratory testing revealed it contains undeclared active ingredients found in prescription erectile dysfunction medications.

A&P Creations LLC announced the recall of its X10 Natural Enhancement Supplement to the consumer level on Sept. 14 after U.S. Food and Drug Administration analysis identified sildenafil and tadalafil in the product. Those compounds are the active ingredients in Viagra and Cialis, respectively, and are not listed on the product’s labeling. The FDA restricts approval of both drugs to use under the supervision of a licensed health care professional. Their presence in an over-the-counter supplement poses significant health risks, particularly for consumers taking nitrate-based medications.

According to the company’s announcement, the undeclared ingredients may interact with nitrates found in prescription drugs such as nitroglycerin, potentially lowering blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol or heart disease frequently take nitrate medications.
As of Sept. 14, A&P Creations said it had received no reports of adverse events related to the recall. The affected product was sold to consumers in the United States through Amazon, Walmart.com and naturefuel.us between Dec. 15, 2024, and June 11, 2026.

A&P Creations stated it purchased and distributed X10 as a finished product and did not manufacture or formulate it. The company initiated the recall after the FDA’s laboratory analysis detected the unlisted ingredients.

The company has ceased distribution of the supplement and is notifying affected customers through direct electronic notifications and marketplace customer notification procedures. Consumers who have the recalled product are urged to stop using it immediately and destroy or dispose of it.

Consumers who have experienced problems potentially related to taking the product should contact their physician or health care provider. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

The recalled product be identified as follows:

Product Description	Lot Number	Expiration br> Date
X10 is a liquid product packaged in a red and gold box containing 7 red lightning bolt-shaped sachets, 15 mL each (105 mL total), with UPC 7708075247094. The original Spanish-language package identifies the product as “X10” and describes it as “Bebida energizante” (energy beverage).	F090824LN16	08/2026
	F170325LN19	03/2027
	F300326LN28	03/2028

Hidden Viagra and Cialis Ingredients Found in biQ-FEL Supplement

CLERMONT, Fla. — A&P Creations LLC is recalling certain lots of its biQ-FEL 500 mL dietary supplement at the consumer level after federal laboratory testing found sildenafil and tadalafil that were not listed on the product label, the company announced Sept. 14, 2026.

The FDA published the recall notice on Sept. 15, 2026. Sildenafil and tadalafil are the active ingredients in the FDA-approved prescription drugs Viagra and Cialis, respectively, which are used to treat erectile dysfunction. FDA approval of those drugs is restricted to use under the supervision of a licensed health care professional.

The undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels, according to the company. People with diabetes, high blood pressure, high cholesterol or heart disease often take nitrates.

As of Sept. 14, 2026, A&P Creations said it had not received any reports of adverse events related to the recall.

The recalled product is biQ-FEL, a liquid packaged in a 500 mL bottle bearing the biQ-FEL name. The label includes Spanish-language text, including “Sabor artificial Hierbabuena.” The product was distributed to consumers in the United States through Amazon, Walmart.com and naturefuel.us.

A&P Creations distributed biQ-FEL as a finished product and did not manufacture or formulate it, the company said. The company decided to recall the product after FDA laboratory analysis identified the unlisted sildenafil and tadalafil.

A&P Creations has ceased distribution of biQ-FEL 500 mL and is notifying affected customers through direct electronic notifications and applicable marketplace customer notification procedures as part of the voluntary recall.

Consumers who have the recalled biQ-FEL 500 mL product should stop using it immediately and are urged to destroy it, the company said. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

It includes:

Lot Number	Expiration Date	UPC/Barcode Identifier
biQ-f001-06-25	05/06/27	biQ-FEL
biQ-003-01-26	01/01/28	7709799120663

Dangerous Undeclared Yohimbine Sparks Nationwide Recall of Business Pill and Branch Manager for Men

GRANT-VALKARIA, Fla. — SUPPLX.com is voluntarily recalling two male sexual enhancement supplements nationwide after FDA laboratory analysis confirmed both contain dangerously high levels of undeclared yohimbine, a substance that can cause severe heart, neurological and psychiatric harm and has been linked to death in overdose cases.
The recall covers Business Pill and Branch Manager for Men, which are marketed as dietary supplements. The company announced the recall Sept. 3, 2026, and the FDA published it Sept. 4, 2026.

SUPPLX.com male sexual enhancement supplements nationwide

According to the company’s announcement, FDA testing confirmed yohimbine in both products even though it is not declared on the labels. Yohimbine is a plant-derived alkaloid formulated for use as a prescription medication, generally as a treatment for erectile dysfunction. It has also been studied for use to promote blood flow and support athletic performance.

The FDA found dangerously high levels of yohimbine in the recalled products, the company said. Yohimbine can cause severe hypertension, tachycardia, and possibly cardiac arrhythmia and myocardial infarction, or heart attacks, especially if the consumer is taking other stimulants such as caffeine or ephedra-containing products or prescription drugs used to treat ADHD.

Severe gastrointestinal distress, including nausea, vomiting, diarrhea and stomach pain, are typical side effects of high doses. The substance can also cause acute neurologic and psychiatric effects, including anxiety, insomnia, mania, psychosis in schizophrenic patients, drowsiness, disorientation, tremors and seizures. Death has been reported in cases of severe overdose.

The recalled products were packaged in single-capsule blister cards and sold in 24-count retail boxes through SUPPLX.com. The recall covers all lots and expiration or best-by dates distributed from Sept. 16, 2023, through June 11, 2026.

Lot and expiration or best-by information appears on the back of each individual blister card. On Business Pill, it appears in the upper-right corner; on Branch Manager for Men, it appears directly above the barcode. No other SUPPLX.com products are included in the recall. SUPPLX.com said it is notifying affected customers directly. Consumers who possess Business Pill or Branch Manager for Men should stop using the product immediately and dispose of any remaining product.

Consumers who have experienced health problems that may be related to use of either product should contact a physician or other health care provider. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Weight-Loss Supplement Recalled Nationwide After FDA Finds Antidepressant and Toxic Chemical in AM/PM Pills

DAVIE, Fla. — Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0 nationwide at the consumer level after FDA laboratory analysis found undeclared fluoxetine in the product’s daytime tablets and undeclared 2,4-dinitrophenol, or DNP, in its nighttime tablets, the company announced Aug. 27, 2026. The FDA published the recall notice Aug. 31, 2026.

Fluoxetine is the active ingredient in an FDA-approved drug used to treat conditions including depression, bulimia and obsessive-compulsive disorder. DNP is a toxic substance commonly used as a pesticide, dye, wood preservative and herbicide. It is illegally marketed as a weight-loss product and is not approved by the FDA for any use.
Products containing fluoxetine and DNP cannot be marketed as dietary supplements. According to the company, Lipofit Extreme Fat Burner 2.0 is an unapproved new drug for which safety and efficacy have not been established, making it subject to recall.

The recalled product is promoted and sold for weight loss. When tainted with both fluoxetine and DNP, it can cause a wide range of serious and potentially life-threatening adverse effects, the company said. Users may experience nausea, vomiting, sweating, dizziness and headaches, as well as dangerous heart rhythm problems, rapid heart rate and cardiac arrest, which can result in sudden death.

Neurological effects including seizures may also occur, along with abnormal bleeding and suicidal thoughts. Long-term exposure carries additional risks, including damage to the eyes, skin, bone marrow, nervous system and heart, as well as dangerously high body temperature and rapid breathing. When combined with certain other medications, the risk of fatal cardiac events is further elevated.

To date, Ana Salazar Modela Tu Cuerpo Inc. said it has not received any known reports of adverse events related to the recall. The tainted product is marketed as a dietary supplement and is packaged as AM and PM tablets. The recalled product is identified as Lot 25M12F, with an expiration date of 09/2027. It was distributed in the United States directly to individual consumers through online sales.

Ana Salazar Modela Tu Cuerpo Inc. said it has stopped selling and promoting the affected product and has quarantined all remaining inventory under its control.

Consumers who have the affected product should stop using it immediately, keep it separated from children and other people, and should not sell, give or transfer it to anyone else. Consumers who purchased the recalled product should contact Ana Salazar Modela Tu Cuerpo Inc. at (954) 305-1004 or yandrydy@gmail.com for instructions regarding its disposition. Consumers should not mail or dispose of the product until appropriate return or disposition instructions are provided.

Consumers should contact their physician or health care provider if they have experienced any problems that may be related to taking or using the product. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.